Christin Andersen-Lund

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Limited clinical utility of mutation-based circulating tumor DNA detection in pseudomyxoma peritonei.

Limited clinical utility of mutation-based circulating tumor DNA detection in pseudomyxoma peritonei.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: February 23, 2026

Naïve adaptive immune receptor repertoires in celiac disease assessed by machine learning; impact of the HLA-DQ2.5 allotype on the TCR repertoire.

Naïve adaptive immune receptor repertoires in celiac disease assessed by machine learning; impact of the HLA-DQ2.5 allotype on the TCR repertoire.

Journal: Immunogenetics
Published: January 28, 2026

High prevalence of KRAS and GNAS mutations in pseudomyxoma peritonei underscores opportunities for targeted therapeutic strategies.

High prevalence of KRAS and GNAS mutations in pseudomyxoma peritonei underscores opportunities for targeted therapeutic strategies.

Journal: Pleura and peritoneum
Published: September 19, 2025

Transcription termination counteracts DNA damage after WEE1 inhibition.

Transcription termination counteracts DNA damage after WEE1 inhibition.

Journal: Nucleic acids research
Published: September 06, 2024

Enrichment of Cancer-Associated Fibroblasts, Macrophages, and Up-Regulated TNF-α Signaling in the Tumor Microenvironment of CMS4 Colorectal Peritoneal Metastasis.

Enrichment of Cancer-Associated Fibroblasts, Macrophages, and Up-Regulated TNF-α Signaling in the Tumor Microenvironment of CMS4 Colorectal Peritoneal Metastasis.

Journal: Cancer medicine
Published: August 29, 2024

Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy and Liver Resection is a Treatment Option for Patients With Peritoneal and Liver Metastases From Colorectal Cancer.

Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy and Liver Resection is a Treatment Option for Patients With Peritoneal and Liver Metastases From Colorectal Cancer.

Journal: Annals of surgery
Published: August 26, 2024

Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer.

Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer.

Journal: Journal of translational medicine
Published: March 20, 2024

T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastases.

T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastases.

Journal: GigaScience
Published: September 30, 2022

The immuneML ecosystem for machine learning analysis of adaptive immune receptor repertoires.

The immuneML ecosystem for machine learning analysis of adaptive immune receptor repertoires.

Journal: Nature machine intelligence
Published: November 01, 2021

Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei.

Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei.

Journal: Journal for immunotherapy of cancer
Published: September 27, 2021

A comprehensive framework for analysis of microRNA sequencing data in metastatic colorectal cancer.

A comprehensive framework for analysis of microRNA sequencing data in metastatic colorectal cancer.

Journal: NAR cancer
Published: June 18, 2021

Omics analyses in peritoneal metastasis-utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative review.

Omics analyses in peritoneal metastasis-utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative review.

Journal: Journal of gastrointestinal oncology
Published: May 10, 2021
Showing 1-12 of 18

Last Updated: 09/26/2026